ESG Strategy

Our ESG strategy

2022 saw the approval of our ESG Strategy, a key milestone in the development of the “ESG Strategy” section of our Strategic plan, establishing a roadmap for sustainability in the coming years.

The set of measures included in the strategy fall into 7 groups:

  • Good governance and Ethics
  • Product innovation
  • People
  • Commitment to the health system
  • Supply chain
  • Environmental management
  • Social contribution
Our ESG strategy
Past and present: Statement of Non-Financial Information
Our sustainable performance in the past, now and in the future

Every year we disclose our sustainability performance through our Statement of Non-Financial Information. This means that our stakeholders have all the information they need about our performance and our progress with our ESG Strategy.

Statement of Non-Financial Information 2023
Statement of Non-Financial Information 2022
Statement of Non-Financial Information 2021
Statement of Non-Financial Information 2020
Statement of Non-Financial Information 2019
Sustainability
FUTURE: Our production plant is a benchmark in sustainable building

The new pharmaceutical production plant in Derio (Bizkaia) has LEED GOLD “Leadership in Energy and Environmental Design” certification.

What will be our main pharmaceutical plant has become a benchmark in terms of energy efficiency and carbon emissions reduction, creating a healthier and safer place for its occupants.

Notable aspects of the sustainability measures considered in the design are:

  • Installation of renewable energy generation systems (photovoltaic panels).
  • Installation of green roofs.
  • High performance hot water generation systems (heat pumps).
  • Low consumption lighting systems (LED lights) with automatic operation management.
  • Insulation systems better than required by regulations to minimise losses.

Environment
Commitment to the environment
Social
Commitment to society
Good governance
Good governance commitment

Discover more

You might also be interested in
R&D+i
We are dedicated to developing innovative and high-quality solutions with an integral approach to health.
Investors
Find out more about our vision for the future and all our financial information.